Vystar Corporation

What they do

Vystar operates through three brands: Vytex, a patented ultra-low protein natural rubber latex raw material; RxAir, which makes FDA-cleared UV air purifiers and replacement cartridges; and FEC, a green energy technology developer. The company sells RxAir units online and through distributors, and supplies Vytex latex to manufacturers for end products like gloves and condoms. Vystar also had a majority stake in Rotmans Furniture, but its activities are in discontinued operations.

Revenue drivers

• RxAir air purification systems — Sells residential and commercial units (RX400, RX800 in testing) plus ViraTech replacement cartridges for roughly 25,000 previously sold units. Revenue has been minimal, with quarterly sales under $21,000 in 2025-2026.
• Vytex natural rubber latex — Markets ultra-low protein latex raw material to manufacturers; revenue from this segment is not separately disclosed in the excerpts but is a core strategic focus.
• Fluid Energy Conversion (FEC) — Early-stage green energy technology; no revenue mentioned in the filings.
• Rotmans Furniture (discontinued) — All activities included in discontinued operations, so no current revenue contribution.

Recent performance

Annual revenue declined from $525,883 in 2023 to $135,969 in 2024 and $54,821 in 2025. The company reported a net loss of $1.5 million in 2025 after a $759,513 gain in 2024. Quarterly revenue continued to shrink, from $20,385 (Sep 2025) to $6,147 (Mar 2026) and $7,767 (Jun 2026). Operating cash flow was negative $180,393 in 2025. As of June 30, 2026, cash was $109,845 and shareholder equity was negative $7.1 million.

Strategy

Management plans to finance operations through cash on hand, private placements, and increased RxAir sales via third-party wholesalers and retailers. For Vytex, they are working with CMC Global on market development and production trials, including dry rubber for tire companies. For RxAir, they are developing new products like the RX800 (in testing) and a smaller USB-charged unit for automobiles and refrigerators, while exploring production options for a prototype renamed RX600.

Risks

• Going concern risk — Vystar does not generate enough cash to finance operations and has an accumulated deficit of $61.4 million as of December 31, 2025.
• Limited revenue generation — Annual revenue has been under $200,000 since 2022, down from $1.7 million in 2021.
• Early-stage and unproven products — Sales depend on new product launches (RX800, RX600) that are still in testing or prototype stages.
• Tariff and supply chain exposure — Management notes U.S. government tariffs may impact future production of RxAir products.

Outlook

Management expects to raise capital and grow RxAir sales through new distribution partnerships. They aim to launch the RX800 and a smaller USB-charged unit in 2026. However, they acknowledge ongoing losses and uncertainty about achieving profitability, given the early stage of their business.